Hosted on MSN16d
Glox to develop precision antibiotics for cystic fibrosisCollaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. The funding of up to £500,000 is provided by LifeArc, a medical research ...
Dr George Owiti, a radiographer at Kericho County Hospital examines the Chest CT results of a patient admitted ... while the disease is already at an advanced stage, according to the National ...
Glox Therapeutics Ltd. has been awarded a share of a £3 million (US$3.7 million) collaborative discovery program launched by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) syndicate. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback